TY - CHAP M1 - Book, Section TI - Disorders of Calcium and Phosphorus Homeostasis A1 - Pai, Amy Barton A2 - DiPiro, Joseph T. A2 - Talbert, Robert L. A2 - Yee, Gary C. A2 - Matzke, Gary R. A2 - Wells, Barbara G. A2 - Posey, L. Michael PY - 2017 T2 - Pharmacotherapy: A Pathophysiologic Approach, 10e AB - Patient Care Process for the Management of HypercalcemiaCollectPatient characteristics (e.g., age, race, sex,)Patient history (past medical, family, social—dietary habits)Evaluate symptoms (see Hypercalcemia-Clinical Presentation)Current medications, including over-the-counter medications, herbal products, nutritional supplementsObjective data (see Hypercalcemia-Clinical Presentation)Blood pressure, heart rate, height, weightLabs (serum calcium and albumin, ionized calcium (if available))Other diagnostic tests when indicated (e.g., ECG)AssessPlausible etiology for hypercalcemia (see Table 50-1)Acuity of symptoms and urgency for treatment (see Figure 50-2)Current medications and dietary intake that may contribute to or worsen hypercalcemiaKidney function (e.g., creatinine clearance)Serum calcium goal Plan*Pharmacotherapy based on etiology of hypercalcemia, acuity of symptoms urgency of treatment, and kidney functionDetermine specific dose, route of administration, frequency of administration, and anticipated duration of treatment (see Table 50-2) Monitoring parameters including efficacy (e.g. reduction in serum calcium, resolution of symptoms), safety (medication-specific adverse effects), and timeframe (see Table 50-2)Patient education (e.g., purpose of treatment, drug therapy, expected time to reduce calcium, need for future medications)Implement*Provide patient education regarding all elements of treatment planSchedule follow-up according to etiology of hypercalcemia, acuity of original symptoms, and urgency for treatmentFollow-up: Monitor and EvaluateMeasure serum calcium to determine responsePresence of adverse effectsConsider alternative pharmacotherapy if efficacy goals not achieved or adverse effects observed*Collaborate with patient, caregivers, and other health professionals SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1148574490 ER -